MicroTech Medical (Hangzhou) Co (2235.HK) Stock Price

MicroTech Medical (Hangzhou) Co Price

CLOSED
5.88
​
Market closed

Revenue has compounded at 52.8% per year over the past 6 years to 769.37 M CNY. MicroTech Medical (Hangzhou) Co's net margin stands at 6.1%, up from -31.8% several years earlier. Analysts set a median price target of 6.44 CNY, implying 9.5% above the current price. Of 9 analysts, 0 rate the stock a buy — an overall Sell consensus.

MicroTech Medical (Hangzhou) Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MicroTech Medical (Hangzhou) Co business model & stock analysis

MicroTech Medical (Hangzhou) Co Ltd operates in the Health Care sector, specializing in the research, development, manufacture, and commercialization of diabetes management medical devices and consumables. Headquartered in Hangzhou, China, the company employs 659 full-time staff and went public on 19 October 2021. Its commercialized products include the Equil insulin pump system, blood glucose monitoring systems, and the AiDEX G7 continuous glucose monitoring system, with additional products like artificial pancreas under development. The company sells its products in international markets including the United States and the European Union.

Frequently asked questions about MicroTech Medical (Hangzhou) Co

Analysts currently set an average price target of 6.44 CNY for the MicroTech Medical (Hangzhou) Co stock (median: 6.44 CNY), implying +9.5 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the MicroTech Medical (Hangzhou) Co stock: 0 recommend buying, 2 holding and 7 selling. For 2026, analysts expect MicroTech Medical (Hangzhou) Co to generate revenue of 992.29 M CNY and earnings per share of 0.25 CNY.

Converted at the current exchange rate, the MicroTech Medical (Hangzhou) Co share trades at 0.78 EUR (5.88 CNY).

The expected revenue of MicroTech Medical (Hangzhou) Co is 992.29 M CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of MicroTech Medical (Hangzhou) Co is 96.53 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of MicroTech Medical (Hangzhou) Co is currently 23.28. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the MicroTech Medical (Hangzhou) Co stock.

The price-to-sales ratio (P/S) of MicroTech Medical (Hangzhou) Co is currently 2.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the MicroTech Medical (Hangzhou) Co stock.

The Eulerpool Quality Score for MicroTech Medical (Hangzhou) Co is 5/10.

The ISIN of MicroTech Medical (Hangzhou) Co is CNE100004QN6. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of MicroTech Medical (Hangzhou) Co is 2235.HK. The ticker symbol is used to trade MicroTech Medical (Hangzhou) Co shares on the stock exchange.

Fair ValueTerminal
6.06 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
1.17 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Oct 19, 2021
ISIN
CNE100004QN6
Cusip
Y60235101
Market capitalization
2.46 B CNYMid Cap
52-Week Range
PEG
1.38
P/E ratio
P/Ee 2026
25.45
P/Ee 2027
13.49
P/Ee 2028
10.37
P/S
P/Se
2.26
EV/EBIT
15.77
P/B Ratio
1.05
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.91 %
Last updated Oct 19, 2026, 12:43 AM

MicroTech Medical (Hangzhou) Co Peer Group

MicroTech Medical (Hangzhou) Co FIGI

2235:HK · BBG012V29YT0